Gene Therapies

Learning Objectives

  •  Become familiar with the field of gene therapy 
  • Gain understanding of the use recombinant AAV vectors in gene therapy 
  • Introduction to genome editing and gene regulation technologies 
  • Understand the considerations for designing nonclinical programs 
  • Nonclinical safety evaluation strategies for gene therapy investigational products 
Course summary
Course opens: 
03/22/2022
Course expires: 
03/31/2027
Cost:
$25.00
Part of: 
Therapeutic Modalities
Rating: 
0

Kathleen Meyer, PhD
Vice President, Nonclinical Development
Sangamo Therapeutics Incorporated
 

Price

Cost:
$25.00
Please login or register to take this course.